<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>IQAC - Institut de Qu&#xED;mica Avan&#xE7;ada de Catalunya - CSIC</provider_name><provider_url>https://www.iqac.csic.es/en/</provider_url><title>Nanomedicine for Therapeutic Applications | IQAC - Institut de Qu&#xED;mica Avan&#xE7;ada de Catalunya - CSIC</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="0Ov9FtgyO8"&gt;&lt;a href="https://www.iqac.csic.es/en/grupos-investigacion/nanomedicine-for-therapeutic-applications/"&gt;Nanomedicine for Therapeutic Applications&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://www.iqac.csic.es/en/grupos-investigacion/nanomedicine-for-therapeutic-applications/embed/#?secret=0Ov9FtgyO8" width="600" height="338" title="&#x201C;Nanomedicine for Therapeutic Applications&#x201D; &#x2014; IQAC - Institut de Qu&#xED;mica Avan&#xE7;ada de Catalunya - CSIC" data-secret="0Ov9FtgyO8" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script&gt;
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://www.iqac.csic.es/wp-includes/js/wp-embed.min.js
&lt;/script&gt;
</html><thumbnail_url>https://www.iqac.csic.es/wp-content/uploads/2026/05/nanomedicina-aplicaciones-terapeuticas.jpg</thumbnail_url><thumbnail_width>2000</thumbnail_width><thumbnail_height>1331</thumbnail_height><description>The Nanomedicine for Therapeutic Applications group develops advanced therapeutic strategies based on the design of smart nano- and biocarriers for the targeted delivery of drugs, nucleic acids, and proteins. These nanocarriers are designed to improve the stability, specificity, and intracellular delivery of therapeutic agents, increasing their efficacy and minimizing side effects. We work with diverseContinue reading</description></oembed>
